Clinical Trials in the United States: Successes, Challenges and Opportunities

On April 10th, 2010, posted in: Cancer 101 by

On April 19, 2010 the National Coalition for Cancer Research conducted a “Cancer 101” briefing to discuss the current and future cancer clinical trials enterprise. The briefing showed how today’s clinical trials are being designed to bring clinical research to more patients and, using sophisticated health information technologies, are already heavily engaged in Comparative Effectiveness Research and personalized medicine. The briefing also focused on regulatory and legal issues that, at times, impede the progress of important clinical trials.

Speakers for the briefing were:

Robert L. Comis, M.D., President and Chairman, Coalition of Cancer Cooperative Groups, Philadelphia, Pennsylvania
Michael A. Caligiuri, MD, Center Director, The Ohio State University Comprehensive Cancer Center –Arthur G. James Cancer Hospital and Solove Research Institute, Columbus, Ohio
Daniel Sullivan, M.D., Executive Vice President & Associate Center Director for Clinical Investigations, Moffitt Comprehensive Cancer Center, Tampa, Florida

Documents:
NCCR_COMIS_Cancer_101_Congressional_Briefing_04-19-10
NCCR Cancer 101 Clincial Trials Yates Remarks
Mike Caligiuri Presentation
Congressional Staff Briefing–Sullivan

Comments are closed.